Background. Candida species are the fourth leading cause of nosocomial bloodstream infections in the United States. Unfortunately, detection, identification and susceptibility testing using standard instrumented blood culture systems and routine microbiological techniques may take 4-10 days. Moreover, sensitivity of routine blood cultures for candidemia is only ~50 to 75%. The T2 Candida Panel (T2CP) is an FDAapproved assay that rapidly detects the presence of five Candida species directly from whole blood in 3-5 hours. We examined mortality and antifungal therapy (AFT) decisions based on positive (pos) results of a T2CP in patients with negative (neg) blood cultures.
Utility of Aspergillus Galactomannan Assay in Allogeneic Stem
Background. Allogeneic hematopoietic stem cell transplantation (HSCT) is a valuable treatment option for patients with some blood/malignant disorders. However, this procedure may be complicated by life-threatening infections, including invasive aspergillosis (IA). Diagnosis of IA is challenging due to nonspecific symptoms that present similar to other infections; and delays in initiation of treatment are associated with poor outcomes. The galactomannan assay (GM) is a widely used test for the early diagnosis of IA and allows for prompt initiation of antifungal therapy. However, a positive (+) GM result requires further workup for a definitive diagnosis. Furthermore, false-positives can lead to unnecessary treatment with expensive and potentially toxic antifungal medications. At UC San Diego Health, allogeneic HSCT patients not on mold-active agents for antifungal prophylaxis have GM tested weekly until 100 days post-HSCT. This study aims to describe the utility of routine GM assays in this HSCT population.
Methods. This is a retrospective single-center study of patients >18 years of age post-allogeneic HSCT at UC San Diego Health from January 2015 to December 2016 with GM results reported in the electronic medical record. Data includes patient demographics, GM results up to 100 days post-HSCT, antifungal prophylaxis, further testing performed, diagnosis of possible, probable and proven IA, and outcome of infection.
Results. In total, 108 patients met criteria for enrollment in this study. There were a total of 1,354 GM results, of which only 2.8% (38) were positive (≥1 +GM) in 25 patients (23% of all patients). Of these, 20 of 25 (80%) were found to be false-positives. In total, 7 of 108 patients had a diagnosis of possible or probable IA. Of the seven, two had 0 +GM, and two had 1 +GM. In the two with 1+GM, IA diagnosis was notably made prior to the +GM result. In only three of the seven cases did +GM screening lead to diagnosis of IA; of these, two patients had acute GVHD and one developed infection during neutropenia, in the first 2 weeks post-HSCT.
Conclusion. Routine GM testing adds to cost and is not a useful predictor of IA infection in the studied population. Studies to determine what populations, if any, would most benefit from routine pre-emptive GM or other fungal screening are needed.
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Trypanosama cruzi DNA Detection by PCR in Dried Blood Spots Preserved in Filter Paper

Background. Early diagnosis of Congenital Chagas
Disease is important to initiate efficient treatment, so it is necessary to develop techniques with lower detection limits and greater specificity like PCR. The lack of validated protocols and the need to send samples to be analyzed in experienced centers makes dried blood spots preserved in filter paper an attractive alternative for the conservation and handling of samples. The aim of this study was to optimize the detection of Trypanosoma cruzi DNA from dried blood spots preserved in filter paper.
Methods. Fixed sections of Whatman filter paper with different concentrations of T. cruzi were prepared (10 4 /mL at 10 -1 /mL) and stored at room temperature, 4 and −20°C in the presence or absence of a desiccant. Samples (8 mm 2 ) were taken at 7, 60, 90 and 240 days of preservation. Endpoint PCR, targeting 18S gene, was used for the detection of T. cruzi DNA directly on the filter paper.
Results. T. cruzi DNA was detected at all sampling times up to the 10 2 /mL concentration independently of conservation. The effect of humidity was observed at 240 days preservation with the observation of faded bands in agarose gels. For the 10 1 / mL concentration, T. cruzi DNA was detected only at 7 days regardless of preservation. When comparing T. cruzi DNA detection using increasing sections of filter paper (8, 16 and 24 mm 2 ), T. cruzi DNA was detected in all areas tested in the concentration of 10 1 parasites/mL and only when using 24 mm 2 for the concentration of 1 parasite/mL. Conclusion. Dried blood spots preserved in filter paper allowed detection of T. cruzi DNA by endpoint PCR in the different conservation conditions up to 8 months. The detection of parasite DNA was improved by increasing the area of filter paper tested. The conservation of blood on filter paper would provide a safe transport of samples at room temperature to distant specialized laboratories to perform diagnosis using molecular techniques.
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